
News|Articles|February 3, 2025
Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation
Author(s)PurpleLab
This white paper presents findings from the PurpleLab Migraine Study, which leverages real-world data to analyze migraine prevalence, treatment variations, and provider insights. The study examines data from approximately 10 million Americans diagnosed with migraines, focusing on patient demographics, treatment pathways, and healthcare provider specialties. Key findings include the high prevalence of migraines among females aged 18-54, racial and ethnic disparities in treatment, and the significant role of specialized providers like psychiatrists and neurologists in managing migraine care. It highlights the importance of tailored treatment approaches and the potential benefits of complementary and alternative medicine therapies.
Trending on Applied Clinical Trials Online
1
ACT Brief: Bridging Site-Sponsor Data Gaps, Major Study Retraction, and TNBC First-Line Approval
2
ACT Brief: DIA Leadership Amid Uncertainty, Reimagining CRO Contracts, and Eli Lilly Expansion
3
Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation
4
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
5